NSE:TORNTPHARM (India)
Â
Shs Dematerialised
₹
4,961.5
-103.7 (-2.05%)
Jul 24
Business Description
Torrent Pharmaceuticals Ltd
ISIN : INE685A01028
Share Class Description:
NSE:TORNTPHARM: Shs DematerialisedTotal Employee Number:
17,729Compare
Compare
Traded in other countries / regions
TORNTPHARM.India Index Membership
NIFTY 500 IPO Date
2002-11-25Description
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, Vitamins Minerals Nutrients (VMN), and gastrointestinal therapeutic areas. It operates through the Generic Formulation Business segment. Geographically, the business activities are carried out across Indian and International markets. Maximum revenue for the company is generated from its operations in India.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 1.79 | |||||
Debt-to-EBITDA | 3.43 | |||||
Interest Coverage | 8.94 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.88 | |||||
Beneish M-Score | -1.82 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.3 | |||||
3-Year EBITDA Growth Rate | 14.9 | |||||
3-Year EPS without NRI Growth Rate | 21.6 | |||||
3-Year FCF Growth Rate | 9.3 | |||||
3-Year Book Growth Rate | 10.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 19.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.83 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.26 | |||||
9-Day RSI | 55.84 | |||||
14-Day RSI | 59.32 | |||||
3-1 Month Momentum % | 9.4 | |||||
6-1 Month Momentum % | 14.55 | |||||
12-1 Month Momentum % | 27.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 0.75 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 292.55 | |||||
Days Sales Outstanding | 62.65 | |||||
Days Payable | 210.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.75 | |||||
Dividend Payout Ratio | 0.53 | |||||
3-Year Dividend Growth Rate | 24.8 | |||||
Forward Dividend Yield % | 0.75 | |||||
5-Year Yield-on-Cost % | 2.42 | |||||
Shareholder Yield % | -2.26 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75.37 | |||||
Operating Margin % | 25.01 | |||||
Net Margin % | 15.73 | |||||
EBITDA Margin % | 31.82 | |||||
FCF Margin % | 17.05 | |||||
OCF Margin % | 21.98 | |||||
ROE % | 26.56 | |||||
ROA % | 8.67 | |||||
ROIC % | 11.87 | |||||
3-Year ROIIC % | 4.13 | |||||
ROC (Joel Greenblatt) % | 51.77 | |||||
ROCE % | 17.05 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 77.63 | |||||
Forward PE Ratio | 69.74 | |||||
PE Ratio without NRI | 75.42 | |||||
Shiller PE Ratio | 118.49 | |||||
Price-to-Owner-Earnings | 64.44 | |||||
PEG Ratio | 5.39 | |||||
PS Ratio | 12.2 | |||||
PB Ratio | 20.02 | |||||
Price-to-Free-Cash-Flow | 71.6 | |||||
Price-to-Operating-Cash-Flow | 55.56 | |||||
EV-to-EBIT | 64.66 | |||||
EV-to-Forward-EBIT | 30.64 | |||||
EV-to-EBITDA | 48.13 | |||||
EV-to-Forward-EBITDA | 30.47 | |||||
EV-to-Revenue | 15.31 | |||||
EV-to-Forward-Revenue | 11.35 | |||||
EV-to-FCF | 90.96 | |||||
Price-to-GF-Value | 1.12 | |||||
Price-to-Projected-FCF | 5.11 | |||||
Price-to-DCF (Earnings Based) | 6.97 | |||||
Price-to-DCF (FCF Based) | 3.69 | |||||
Price-to-Median-PS-Value | 2.12 | |||||
Price-to-Peter-Lynch-Fair-Value | 5.4 | |||||
Earnings Yield (Greenblatt) % | 1.55 | |||||
FCF Yield % | 1.25 | |||||
Forward Rate of Return (Yacktman) % | 15.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Torrent Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 137,530 | ||
| EPS (TTM) (₹) | 63.92 | ||
| Beta | 0.602 | ||
| 3-Year Sharpe Ratio | 1.27 | ||
| 3-Year Sortino Ratio | 2.41 | ||
| Volatility % | 16.09 | ||
| 14-Day RSI | 59.32 | ||
| 14-Day ATR (₹) | 133.66467 | ||
| 20-Day SMA (₹) | 4874.645 | ||
| 12-1 Month Momentum % | 27.97 | ||
| 52-Week Range (₹) | 3480.6 - 5085.8 | ||
| Shares Outstanding (Mil) | 380.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Torrent Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Torrent Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-06 18:30 | In 106 days | ||
| Second quarter earnings results for 2027 | 2026-11-06 | In 104 days | ||
| First quarter earnings conference call for 2027 | 2026-07-30 17:30 | In 6 days | ||
| First quarter earnings results for 2027 | 2026-07-30 | In 5 days | ||
| General meeting for 2026 | 2026-07-23 09:30 | 5,033.40 (-0.64%) | ||
| Annual report for 2026 | 2026-06-01 | 4,410.80 (-3.16%) | ||
| INR 9.000000 Cash Dividend | 2026-05-29 | 4,537.80 (+0.00%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-22 17:30 | 4,469.20 (-1.07%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-22 | 4,469.20 (-1.07%) | ||
| INR 29.000000 Cash Dividend | 2026-02-18 | 4,258.40 (-0.31%) |
Show
Entries
Torrent Pharmaceuticals Ltd Frequently Asked Questions
What is Torrent Pharmaceuticals Ltd(NSE:TORNTPHARM)'s stock price today?
The current price of NSE:TORNTPHARM is ₹4961.50. The 52 week high of NSE:TORNTPHARM is ₹5085.80 and 52 week low is ₹3480.60.
When is next earnings date of Torrent Pharmaceuticals Ltd(NSE:TORNTPHARM)?
The next earnings date of Torrent Pharmaceuticals Ltd(NSE:TORNTPHARM) is 2026-07-30.
Does Torrent Pharmaceuticals Ltd(NSE:TORNTPHARM) pay dividends? If so, how much?
The Dividend Yield %  of Torrent Pharmaceuticals Ltd(NSE:TORNTPHARM) is 0.75% (As of Today), Highest Dividend Payout Ratio of Torrent Pharmaceuticals Ltd(NSE:TORNTPHARM) was 0.64. The lowest was 0.27. And the median was 0.49. The  Forward Dividend Yield % of Torrent Pharmaceuticals Ltd(NSE:TORNTPHARM) is 0.75%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Torrent Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers